It has been claimed that, in patients with amyloidosis, the presence of amyloid material in the skin may be demonstrated by the intracutaneous injection of Congo red (Philpott and Freshman, 1936; Nomland, 1936) . In the presence of amyloidosis, the area of staining is said to be more intense and to persist for a longer time than in normal skin.
Recently this technique has been employed by Laine, Holopainen, and Makinen (1956) in a series of patients with rheumatoid arthritis. The fixation of the dye in the skin was measured by the time taken for the stained area to fade to a standard intensity and this was found to be significantly longer in 55 patients with rheumatoid arthritis than in thirty normal control subjects. From these results, Laine and his co-workers concluded that this phenomenon might be due to the presence of amyloid in the skin of patients with rheumatoid arthritis. This seemed quite possible since, with the decline of tuberculosis, rheumatoid arthritis is one of the chief causes of secondary amyloid. At the Postgraduate School of Medicine, London, amyloid was found in eight out of 48 autopsied cases (Missen and Taylor, 1956) .
Using a modified method of assessment, we have confirmed Laine's results, but our experience leads us to differ somewhat from Laine and his colleagues in their tentative conclusions cited above.
Methods
An autoclaved solution of I per cent. Congo red in normal saline was used, since the aqueous solution used by Laine and others was found to produce some pain on injection. This solution may be autoclaved repeatedly without change in its staining properties and no discomfort or untoward reactions occurred after its injection. A tuberculin syringe was used and exactly 0 1 ml. was injected into the skin of the flexor surface of the forearm of each subject.
During the first 24 hours, the pink stain spread to an area of between 1 and 2 cm. diameter, slightly larger in children than in adults, and usually, contrary to expectation, less intense in adults. After 24 hours there was no further spread and the stain gradually faded. It was always more marked at the periphery and the fading was complete by about 9-12 days in the "control" cases, but lasted for a longer period-between 17 and 20 days-in the cases with rheumatoid arthritis. The initial intensity of the staining and the rate at which it subsequently faded varied from individual to individual. The intensity of the staining at any stage was estimated by matching with a series of arbitrary standards consisting of strips of filter paper (Whatman No. 1) which had been soaked for about 2 minutes in an aqueous solution of Congo red, and then dried and kept in the dark. In these test specimens no fading occurred within 7 weeks. Eight solutions were used of the following dilutions: 1*0, 0 5, 0 25, 0 125, 0 062, 0 031, 0 016, and 0 008 per cent. For convenience, these standards were numbered 1 to 8, the last numeral corresponding to the weakest solution of Congo red (0-008 per cent.). All readings were made in daylight and recorded in terms of these standard colour units.
Interpretation
It was found that, when readings were made in this manner, different observers might match the same stained area with different standards, especially as the staining became less intense. In order to assess the size of this observer variation, some preliminary trials were carried out. Two groups of ten patients each (five with Still's disease and five convalescent from rheumatic fever) were injected: two observers made "blind" independent daily readings (i.e. without reference to preceding readings) for 5 to 7 days. In the first group (read by one medical and one lay observer), 30 per cent. of the ninety readings differed by one colour unit and about 3 per cent. differed by two units. In the second group (read by the same medical observer and another), the readings also differed by one unit in 30 per cent. of cases, but differences of more than one unit did not occur. One observer tended to read consistently higher than the other.
To minimize this slight observer error, to compensate for the differing initial intensity of staining in different subjects, and because readings made during the first week were subject to less variation than those made later, it was decided to utilize the difference between the reading at 24 hours after injection and another reading of the same spot by the same observer 5 to 7 days later. The difference between these two readings, divided by the time in days which elapsed between them, gives an estimate of the amount of fading which has taken place each day. This "fading rate" varied from 0 to 1 6 units daily in the 120 subjects tested. A rate of 0 indicates no fading over the week, and one of 1-6 indicates rapid fading in 5 to 6 days. When this rate was calculated for the two preliminary trial groups, the same rate was given in five of the ten duplicate readings in the first group, the mean rates for each observer being 0 32 colour units/day and 0-42 colour units/day respectively. In the second group, the same rates were given in eight of the ten duplicate readings, the means being 0-60 and 0 53 units respectively. (Fig. 2, overleaf) . The rate of fading of the Evans blue (as measured by similar staining standards) was almost identical in the two groups, i.e. rheumatoids 0 22 and controls 0-25 colour units daily. The rate of fading of the Congo red showed a difference: rheumatoids 0 20 and controls 0 55 colour units daily.
Discussion
These results confirm the report of Laine and others (1956) that the skin of patients with rheumatoid arthritis shows a more prolonged fixation of injected Congo red than the skin of normal controls. However, it was felt that several facts made it unlikely that this phenomenon was due to deposits of amyloid as Laine and his co-workers suggested.
Those patients who had had extensive involvement for a long time and who could reasonably be expected to be more likely to have developed amyloid, showed no greater fixation than those in whom the disease was relatively mild and early. Furthermore, the two cases of proven amyloidosis tested did not show any more prolonged fixation than other cases of rheumatoid arthritis of the same age. The increased fixation shown by cases of active rheumatic fever and the demonstrable difference in the three age groups of the control series also suggest that the explanation lies not in amyloid deposition in the skin but rather in a change in the nature or metabolism of one of the normal skin constituents.
Equally, the similarity of fading rates shown by rheumatoid and control patients when Evans blue was injected, and the difference in the same patients with Congo red, make it unlikely that the explanation lies in a difference in peripheral circulation. Dixon, Ramcharan, and Ropes (1955) have reported an increased rate of loss of Congo red from the plasma in adult rheumatoid arthritis patients compared with normal subjects. Thus normal subjects retained in the plasma 70 per cent. of the amount injected after one hour, but the patients with amyloid retained 50 per cent. or less. 114 out of 227 rheumatoid arthritis patients gave values between 50 and 70 per cent. It was possible, they thought, that this represented a subclinical level of amyloidosis or an analogous alteration of the polysaccharide and protein constituents of connective tissue, since amyloid was found in 24 per cent. of eighty autopsied rheumatoid patients and some decreased Congo red plasma retention has also been found in other patients without clinical evidence of amyloidosis but with diseases which could be associated with that complication. Against this interpretation, however, was the failure to find any evidence at all of amyloidosis at autopsy in two patients with Congo red retention of 50 per cent. or less after one hour within 2 weeks of death.
It appears possible that this low plasma retention might be explained by the appearance of a Congo red-avid material in the tissues of rheumatoid subjects. Another abnormality affecting the skin has been described in rheumatoid arthritis and in the acute stages of rheumatic fever (Bywaters, Holborow, and Keech, 1951) , and this may be a related phenomenon. A prolonged reconstitution of the substrate for hyaluronidase was found. In young normal subjects, this substrate reformed more quickly than in the more elderly. If these two phenomena relate to similar substances, one might postulate that in rheumatoid arthritis there is an increased amount in the skin and that degradation is very slow. In young normal subjects there is more present than in the old, but the turnover rate is quicker.
These data confirm the widespread involvement of connective tissue in rheumatoid arthritis and rheumatic fever, and suggest that further attention Rouge Congo intradermique dans 1'arthrite rhumatismale REsuME (1) La coloration vitale de la peau apres injection intradermique de Rouge Congo fut 6tudiee chez 120 sujets.
(2) I1 se produit une fixation prolongee et augmented de ce colorant dans la peau des malades atteints d'arthrite rhumatismale et de rhumatisme articulaire aigu, en comparaison avec les convalescents de rhumatisme articulaire aigu et autres.
(3) 11 existe une difference tres nette selon l'age, les sujets plus jeunes se decolorant plus lentement.
(4) On pense que ce phenomene est dfi a un changement dans la nature ou le metabolisme des constituents du tissu conjonctif plut6t qu'a une alteration de la vascularite ou a un dep6t amyloide.
El rojo Congo intradermico en la artritis reumatoide SUMARIO (1) La coloraci6n vital de la piel despues de inyecciones intradermicas de rojo congo fue estudiada en 120 sujetos.
(2) Se produce una fijaci6n prolongada y aumentada de este tinte en la piel de enfermos con artritis reumatoide y con reumatismo poliarticular agudo, en cornparaci6n con los convalecientes de reumatismo poliarticular agudo y otros.
(3) Existe una diferencia muy marcada segun la edad, produciendose la descoloraci6n mas lentamente en sujetos mas j6venes.
(4) Se cree que este fen6meno se debe mas bien a un cambio en la naturaleza o en el metabolism de los constituyentes del tejido conjuntivo que a una alteraci6n de la vascularidad o a un dep6sito amiloide.
